• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kindly MD, Inc. - Common Stock (NQ: KDLY )

    1.620 -0.040 (-2.41%)
    Streaming Delayed Price Updated: 9:42 AM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 25,411
    Open 1.620
    Bid (Size) 1.540 (1)
    Ask (Size) 1.620 (1)
    Prev. Close 1.660
    Today's Range 1.500 - 1.670
    52wk Range 1.400 - 4.200
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024
    Via ACCESSWIRE
    KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director
    Via ACCESSWIRE

    Performance

    YTD
    -46.36%
    -46.36%
    1 Month
    -9.99%
    -9.99%
    3 Month
    -46.36%
    -46.36%
    6 Month
    -46.36%
    -46.36%
    1 Year
    -46.36%
    -46.36%

    More News

    Read More
    Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    KDLY Stock Earnings: Kindly MD Reported Results for Q2 2024
    Via InvestorPlace
    KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
    Via ACCESSWIRE
    KindlyMD Announces First Quarter 2024 Financial Results and Provides Shareholder Update
    Via ACCESSWIRE
    KindlyMD Announces Successful SAM.gov Registration and Grant Application
    Via ACCESSWIRE
    KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah’s Top Insurance Payors
    Via ACCESSWIRE
    KindlyMD to Present at Upcoming August 2024 Investor Conferences
    Via ACCESSWIRE
    KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment
    Via News Direct
    Topics Cannabis Initial Public Offering
    Exposures Cannabis Securities Market
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors
    Via ACCESSWIRE
    Dow Jumps 200 Points; Honeywell Trims Profit Outlook
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling
    Via ACCESSWIRE
    Top 4 Cannabis Stocks to Watch Ahead of Potential Federal Policy Changes
    Via News Direct
    Topics Cannabis
    Exposures Cannabis
    3 Cannabis Stocks to Buy at a 52-Week Low in July
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    3 IPO Gems Flying Under the Radar (for Now)
    Via InvestorPlace
    Topics Initial Public Offering
    Exposures Securities Market
    Here's How To Enhance Marijuana Therapies: KindlyMD And Curaleaf Collab Provide More Resources And Information To Utah Patients
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah
    Via ACCESSWIRE
    KCSA Cannabis Virtual Investor Conference Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.